BIOQUAL, Inc.
BIOQ
$75.00
-$5.00-6.25%
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 15.87M | 15.58M | 16.07M | 14.11M | 16.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.87M | 15.58M | 16.07M | 14.11M | 16.68M |
| Cost of Revenue | 13.33M | 12.56M | 11.13M | 13.78M | 13.04M |
| Gross Profit | 2.54M | 3.02M | 4.94M | 323.70K | 3.64M |
| SG&A Expenses | 1.97M | 1.86M | 6.00M | 1.94M | 1.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.31M | 14.41M | 17.13M | 15.72M | 14.85M |
| Operating Income | 562.40K | 1.17M | -1.06M | -1.61M | 1.83M |
| Income Before Tax | 668.60K | 1.24M | -1.04M | -1.61M | 1.83M |
| Income Tax Expenses | 183.90K | 341.70K | -338.90K | -470.50K | 535.00K |
| Earnings from Continuing Operations | 484.70K | 899.50K | -702.10K | -1.14M | 1.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 484.70K | 899.50K | -702.10K | -1.14M | 1.29M |
| EBIT | 562.40K | 1.17M | -1.06M | -1.61M | 1.83M |
| EBITDA | 1.20M | 1.81M | -432.70K | -996.50K | 2.39M |
| EPS Basic | 0.54 | 1.01 | -0.79 | -1.27 | 1.45 |
| Normalized Basic EPS | 0.47 | 0.87 | -0.73 | -1.13 | 1.28 |
| EPS Diluted | 0.54 | 1.01 | -0.79 | -1.27 | 1.45 |
| Normalized Diluted EPS | 0.47 | 0.87 | -0.73 | -1.13 | 1.28 |
| Average Basic Shares Outstanding | 894.40K | 894.40K | 894.40K | 894.40K | 894.40K |
| Average Diluted Shares Outstanding | 894.40K | 894.40K | 894.40K | 894.40K | 894.40K |
| Dividend Per Share | -- | -- | 0.50 | -- | -- |
| Payout Ratio | 92.27% | -- | 0.00% | 0.00% | 69.13% |
